The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.
Overestimating the bleeding risk of anticoagulants may lead to poor compliance.
Results from IQVIA Institute for Human Data Science's annual report, "Medicine Use and Spending in the U.S."
Physicians have been misapplying the CDC’s 2016 opioid prescribing guideline, causing challenges for some pain patients, according to a new commentary.
Growth is seen in healthcare settings, but still dominated by independent locations.
Bleeding in patients with nonvalvular atrial fibrillation and coronary syndrome was reduced by apixaban versus vitamin K antagonists.
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
While pharmacy benefit managers were grilled about insulin prices at Congressional hearings last week, some PBMs, insurers and pharma makers are already lowering insulin costs.
Walgreens is partnering with VillageMD to create primary care clinics in Texas
The CBD market is anticipated to be worth $20 billion by 2024.